Egypt will receive on Sunday the first shipment of the COVID-19 vaccine developed by British drugmaker AstraZeneca …
Oxford University
-
-
FeatureIndustry & TradeTech/AI
Egypt to receive AstraZeneca’s COVID-19 vaccine in Q1-2021 – official
The coronavirus vaccine British drugmaker AstraZeneca, is developing with the University of Oxford, should arrive in Egypt …
-
FeatureIndustry & TradeTech/AI
AstraZeneca on track to report Oxford coronavirus vaccine data within a week
by Sanaa Allamby Sanaa AllamBritish drugmaker AstraZeneca, working with the University of Oxford, is on track to report early data from …
-
Egypt NewsNews
Egypt reserves doses of anticipated Pfizer and Oxford trial coronavirus vaccines – minister
Egypt has reserved doses of a potential coronavirus vaccine developed by Pfizer Inc and BioNTech that would …
-
International NewsNews
U.S. pledges $1.2 billion to accelerate Oxford University vaccine, secure 300 million doses
The United States has secured almost a third of the first one billion doses planned for AstraZeneca’s …
-
International NewsNews
Oxford University’s coronavirus vaccine candidate shows promise in small study in monkeys
An experimental coronavirus vaccine developed by Oxford University appears to be effective at preventing coronavirus, according to …
-
International NewsNews
Potential coronavirus vaccine could prove efficacy in June; says Oxford professor
Sir John Bell, the Regius Professor of Medicine at Oxford University, announced on Sunday that researchers at …
-
Industry & TradeTech/AI
AstraZeneca say UK researchers should know by July if coronavirus vaccine is effective
The UK researchers will know by July whether its coronavirus vaccine is effective, pharmaceutical giant AstraZeneca said …
-
Citizen JournalismVideo and Commet
Oxford University scientists expect a coronavirus vaccine could be ready by 2020-end
The faster timetable, Oxford University scientists say, is because their vaccine has been in development for decades …
-
A team at Oxford University have started clinical trials of a potential coronavirus vaccine on Thursday called ChAdOx1 nCoV-19.